Holdings in Company

Paris, France and Camberley, UK – 11 March 2022 – Novacyt S.A. (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that it was notified by Biosynex SA (“Biosynex”) on 10 March 2022 that, as at 7 march 2022, Biosynex’s holding in the Company on a voting and capital basis is 5.54% (3,915,350 shares).